Evidence map›Paper›PMID 25492927›Full record

ArticlePhysiological genomics2015

Polycystin-1 and Gα12 regulate the cleavage of E-cadherin in kidney epithelial cells.

Jen X Xu, Tzong-Shi Lu, Suyan Li, Yong Wu, Lai Ding, Bradley M Denker, Joseph V Bonventre, Tianqing Kong

Open access · greenAbstract read
In one paragraph

Article in Physiological genomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. The GPCR properties of polycystin-1- A new paradigm.Frontiers in molecular biosciences · 2022
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Renal ADAM10 and 17: Their Physiological and Medical Meanings.Frontiers in cell and developmental biology · 2018
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Jen X XuRenal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts;
Tzong-Shi LuRenal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts;
Suyan LiDivision of Basic Neuroscience, McLean Hospital, Belmont, Massachusetts;
Yong WuRenal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts;
Lai DingHarvard NeuroDiscovery Center, Boston, Massachusetts; and.
Bradley M DenkerBeth Israel Deaconess Medical Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Joseph V BonventreRenal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts;
Tianqing KongRenal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; tkong@partners.org.
Brigham and Women's Hospital · USBeth Israel Deaconess Medical Center · USHarvard NeuroDiscovery Center · USMcLean Hospital · US

Funding

Research BaseP30DK090868 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI WATNICK, TERRY J · 2010 to 2019
$11.1M
KIDNEY INJURY MOLECULE-1 IN EPITHELIAL REPAIRR01DK072381 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI BONVENTRE, JOSEPH VINCENT · 2005 to 2025
$8.6M
Mechanisms of Ischemic Kidney Injury and RepairR01DK039773 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI JOSEPH VINCENT BONVENTRE · 1987 to 2026
$6.2M
Mechanisms of Ischemic Kidney Injury and RepairR37DK039773 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BONVENTRE, JOSEPH VINCENT · 1993 to 2021
$5.2M
Polycystin-1 Regulation of Galpha 12 and Integrins in Polycystic Kidney DiseaseK01DK080179 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI KONG, TIANQING · 2008 to 2012
$813k
Complement C3 is Essential for Development of Kidney Cysts in ADPKD MiceR03DK096160 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI KONG, TIANQING · 2013 to 2014
$158k
NIDDK NIH HHS 3K01DK-080179NIDDK NIH HHS DK-096160NIDDK NIH HHS K01 DK-080179NIDDK NIH HHS P30 DK090868NIDDK NIH HHS P30DK-090868NIDDK NIH HHS R01 DK039773NIDDK NIH HHS R01 DK072381NIDDK NIH HHS R37 DK039773
6 · The paper itself

Abstract

Interaction of polycystin-1 (PC1) and Gα12 is important for development of kidney cysts in autosomal dominant polycystic kidney disease (ADPKD). The integrity of cell polarity and cell-cell adhesions (mainly E-cadherin-mediated adherens junction) is altered in the renal epithelial cells of ADPKD. However, the key signaling pathway for this alteration is not fully understood. Madin-Darby canine kidney (MDCK) cells maintain the normal integrity of epithelial cell polarity and adherens junctions. Here, we found that deletion of Pkd1 increased activation of Gα12, which then promoted the cystogenesis of MDCK cells. The morphology of these cells was altered after the activation of Gα12. By using liquid chromatography-mass spectrometry, we found several proteins that could be related this change in the extracellular milieu. E-cadherin was one of the most abundant peptides after active Gα12 was induced. Gα12 activation or Pkd1 deletion increased the shedding of E-cadherin, which was mediated via increased ADAM10 activity. The increased shedding of E-cadherin was blocked by knockdown of ADAM10 or specific ADAM10 inhibitor GI254023X. Pkd1 deletion or Gα12 activation also changed the distribution of E-cadherin in kidney epithelial cells and caused β-catenin to shift from cell membrane to nucleus. Finally, ADAM10 inhibitor, GI254023X, blocked the cystogenesis induced by PC1 knockdown or Gα12 activation in renal epithelial cells. Our results demonstrate that the E-cadherin/β-catenin signaling pathway is regulated by PC1 and Gα12 via ADAM10. Specific inhibition of this pathway, especially ADAM10 activity, could be a novel therapeutic regimen for ADPKD.

Indexed as

ADAM ProteinsAnimalsbeta CateninCadherinsDipeptidesDogsEpithelial CellsGene DeletionGTP-Binding Protein alpha Subunits, G12-G13HumansHydroxamic AcidsKidneyMadin Darby Canine Kidney CellsMice, KnockoutMice, TransgenicPolycystic Kidney, Autosomal Dominant3-(formylhydroxyamino)-2-(3-phenyl-1-propyl)butanoic acid (2,2-dimethyl-1-methylcarbamoyl-1-propyl)amideADAM Proteinsbeta CateninCadherinsDipeptidesGTP-Binding Protein alpha Subunits, G12-G13Hydroxamic AcidsTRPP Cation ChannelsADAM10ADPKDE-cadherinG proteinspolycystin-1

Identifiers

PMID25492927
PMCPMC4313070
OpenAlexW2046041368

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.